Safety and efficacy of single agent rovalpituzumab tesirine in small cell lung cancer (SCLC) - 102017

Spotlight
Video

Safety and efficacy of single agent rovalpituzumab tesirine in small cell lung cancer (SCLC)

VJOncology has 824 videos Subscribe Here

Loading........
Description: Press brief by Charles Rudin, MD, PhD of the Memorial Sloan Kettering Cancer Center, New York, NY, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
Shared By : VJOncology
Posted on : 06/29/16
Added : 3 years ago